Sharda Cropchem earnings calls.

Sharda Cropchem delivered Q1 FY27 revenue of Rs 1,074Current reported value: 1,074. No comparable prior figure is available in the source record. crore (up 9Current 9 crore vs previous available quarter 39 crore.% YoY) driven by favorable FX impact (+12.7%) offsetting volume decline (-1.6%). EBITDA grew robustly at 25% to Rs 178Current 178 crore vs previous available quarter 245.5 crore. crore with margin expansion of 220bps to 16.6%Current 16.6% vs previous available quarter 19.1%., supported by improved product mix and strong performance in NAFTA/LATAM. Europe, the largest market, saw temporary revenue softness due to heatwave-affected distributor destocking, though margins improved to 44.2%. PAT came in at Rs 88Current reported value: 88. No comparable prior figure is available in the source record. crore including Rs 7.5 crore forex gain versus Rs 73.1 crore in Q1 FY26; on like-to-like basis PBT grew 16% YoY. Working capital improved by 10 days to 88 daysCurrent 88 days. Reported change: -10 days YoY.. The company maintains FY27 guidance of 10-15% revenue growth with EBITDA margin of 18-20% and gross margin around 35%. Key risks include forex volatility due to EUR/USD sensitivity, unpredictable weather patterns affecting European destocking cycles, and LATAM margin pressure (declined to 16.9% from 28% YoY). Registration pipeline additions have slowed versus historical pace, raising questions on long-term growth visibility.